Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117,273,296
-
Total 13F shares
-
100,246,388
-
Share change
-
+5,811,039
-
Total reported value
-
$1,087,784,815
-
Put/Call ratio
-
97%
-
Price per share
-
$10.84
-
Number of holders
-
197
-
Value change
-
+$60,991,930
-
Number of buys
-
93
-
Number of sells
-
76
Institutional Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q1 2022
As of 31 Mar 2022,
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) was held by
197 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
100,246,388 shares.
The largest 10 holders included
FEDERATED HERMES, INC., STATE STREET CORP, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., Chicago Capital, LLC, VANGUARD GROUP INC, PFM Health Sciences, LP, Fisher Asset Management, LLC, BLAIR WILLIAM & CO/IL, and EDMOND DE ROTHSCHILD HOLDING S.A..
This page lists
198
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.